Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Astria Therapeutics, Inc. (ATXS) had Tangible Shareholders Equity of $223.94M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-94.26M |
|
-- |
|
-- |
|
$111.56M |
|
$-111.56M |
|
$17.30M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-94.26M |
|
$-111.56M |
|
$-111.56M |
|
56.16M |
|
56.16M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$334.64M |
|
-- |
|
$7.72M |
|
$342.36M |
|
$19.13M |
|
-- |
|
$99.29M |
|
$118.42M |
|
$223.94M |
|
|
Tangible Shareholders Equity |
$223.94M |
$223.94M |
|
56.43M |
|
| Cash Flow Statement Financials | |
$-81.21M |
|
$-191.86M |
|
$157.20M |
|
$175.69M |
|
$59.82M |
|
$-115.87M |
|
$13.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
17.49 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-42.09% |
|
-42.09% |
|
-27.53% |
|
-42.09% |
|
$3.97 |
|
$-1.45 |
|
$-1.45 |
|